David J Cha, MD
General Surgery · Dallas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Medical City Transplant, PLLC · 18 clinicians in this group
Looking this up.
Hospitals listed: Medical City Dallas. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cha’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A141946 · Cancelled
Licence status: Cancelled · since 2016 · State University of New York at Stony Brook Health Sciences Center.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas Q5774Physician License · since 2015 · expires 2028-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Medical City Dallas HospitalDallas, TXAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.69 (0.45 to 0.93), Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.29 (0 to 4.92) · 1,684 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.41, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.423, Oct 2024 – Sep 2025
See every measure and the patient survey for Medical City Dallas Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.69 (0.45 to 0.93) | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.29 (0 to 4.92) · 1,684 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.41 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.423 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.7 (0 to 1.6) · 2,078 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.11 (114.97 to 207.25) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 11 · 97 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 372 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 385 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 255 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,930 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 8,773 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.38) · 9,333 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.41 (0.67 to 4.15) · 2,754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.15 (0 to 2.59) · 1,521 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.21 (0 to 2.45) · 2,599 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.1 (7.79 to 16.42) · 1,757 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.48 (0.08 to 2.88) · 990 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.1 (0 to 0.65) · 7,357 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.68 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.767 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.879 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.163 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 190 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 699 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14.4 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -15.8 · 452 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6 · 413 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 632 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.4 to 8.9) · 41 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (7.4 to 16.1) · 41 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.4 · 73 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 19) · 244 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 515 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,291 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 4 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
Original Medicare doctor bills
$55,554
Medicare paid this office $55,554 for 31 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Transplantation of donor kidney | 23 | $42,323 | $1,840 |
| Preparation of donor kidney for transplantation | 22 | $1,158 | $53 |
Who their Medicare patients are
31 Original Medicare patients in 2024. Average age 51 · Women 45% · Health risk score 9.97. Sicker patients than 9 in 10 peers; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 65% · Coronary heart disease 61% · Heart failure 45% · Depression 35%.
The office billed $279,124, Medicare allowed $68,927 and paid $55,554; for 78 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 31 | 78 | 51 | 9.97 | $279,124 | $55,554 |
| 2023 | 41 | 81 | 54 | 9.94 | $215,595 | $50,198 |
| 2022 | 60 | 83 | 57 | 8.17 | $134,509 | $33,680 |
| 2021 | 135 | 246 | 58 | 7.55 | $297,573 | $70,271 |
| 2020 | 161 | 336 | 58 | 7.76 | $379,218 | $91,289 |
| 2019 | 149 | 323 | 59 | 8.90 | $423,287 | $95,684 |
| 2018 | 51 | 111 | 54 | 8.11 | $133,645 | $22,064 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Transplantation of donor kidney | 18 | $33,162 | $1,842 |
| Preparation of donor kidney for transplantation | 17 | $895 | $53 |
2022: 1 service
| Transplantation of donor kidney | 11 | $20,796 | $1,891 |
2021: 5 services
| Transplantation of donor kidney | 19 | $32,447 | $1,708 |
| Return visit (30+ min) | 40 | $4,109 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,474 | $57 |
| Preparation of donor kidney for transplantation | 16 | $860 | $54 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $856 | $78 |
2020: 10 services
| Transplantation of donor kidney | 15 | $26,788 | $1,786 |
| Revision of hemodialysis graft | 21 | $12,316 | $586 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 20 | $10,444 | $522 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $3,434 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,090 | $58 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,311 | $73 |
| Return visit (30+ min) | 19 | $1,165 | $61 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,164 | $58 |
| Preparation of donor kidney for transplantation | 15 | $783 | $52 |
| Complete ultrasound of artery and vein blood flow pre-op assessment on side of body for hemodialysis access | 18 | $356 | $20 |
2019: 8 services
| Transplantation of donor kidney | 25 | $38,289 | $1,532 |
| Revision of hemodialysis graft | 31 | $16,965 | $530 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 20 | $10,933 | $521 |
| Removal of blood clot from hemodialysis graft | 12 | $4,482 | $373 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,059 | $57 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 24 | $1,989 | $80 |
| Preparation of donor kidney for transplantation | 18 | $841 | $47 |
| Hospital discharge day management, 30 minutes or less | 13 | $745 | $57 |
2018: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,810 | $57 |
Money from drug and device companies
$1,549 in 2024
| 2024 | 2 | 3 | None | $1,549 |
| 2023 | 2 | 2 | None | $132 |
| 2022 | 9 | 11 | None | $508 |
| 2021 | 1 | 2 | None | $12 |
| 2020 | 2 | 2 | None | $271 |
| 2019 | 4 | 4 | None | $277 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Davinci Xi | $1,530 | 2 payments
|
| Veloxis Pharmaceuticals | Envarsus | $19 | 1 payment
|
See all 3 published payments
| Intuitive Surgical | Meals · 2024-06-04 | Da Vinci Surgical System | $30 |
| Veloxis Pharmaceuticals | Meals · 2024-05-13 | Envarsus | $19 |
| Intuitive Surgical | Education · 2024-04-29 | Davinci Xi | $1,500 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $132
| GlaxoSmithKline | Arexvy | $118 | 1 payment
|
| Medtronic | Signia | $14 | 1 payment
|
2022: $508
| GlaxoSmithKline | Nucala | $122 | 1 payment
|
| Sanofi-Aventis U.S. | Thymoglobulin | $97 | 1 payment
|
| Veloxis Pharmaceuticals | Envarsus | $90 | 2 payments
|
| Medtronic | V-Loc 180 | $71 | 1 payment
|
| Sanara MedTech | Celleraterx | $36 | 2 payments
|
| LeMaitre Vascular | Artegraft Vascular Graft | $29 | 1 payment
|
| Ethicon US | Ethicon | $27 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $20 | 1 payment
|
| Bard Peripheral Vascular | None | $17 | 1 payment
|
2021: $12
| Sanara MedTech | Celleraterx | $12 | 2 payments
|
2020: $271
| Integra LifeSciences | Codman Certas | $153 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Hyqvia | $118 | 1 payment
|
2019: $277
| Shire North American Group | Hyqvia | $121 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $120 | 1 payment
|
| AbbVie | Skyrizi | $22 | 1 payment
|
| Heron Therapeutics | Htx-011 | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871882209
- Licence
- CA 141946, TX Q5774California A141946: CancelledTexas Q5774: Active
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 204F00000X (204F00000X); Student in a training program (390200000X)
- Mailing address
- 7777 Forest Ln Ste B446, Dallas, TX, 75230
- NPI first listed
- 2011-04-06
- NPI last updated
- 2021-11-05
- NPI record certified
- 2021-11-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305 · 2401 S 31st St, Temple, TX, 76508